Speedy E2 Activators comprise a diverse group of chemical compounds that enhance the functional activity of Speedy E2 through a variety of signaling pathways and mechanisms. Forskolin plays a pivotal role by increasing the levels of cAMP within the cell, thereby activating PKA, a kinase that can potentially phosphorylate proteins within Speedy E2's signaling cascade, thereby enhancing Speedy E2's functional capacity. Sphingosine-1-phosphate (S1P) and Phorbol 12-myristate 13-acetate (PMA) target sphingosine-1-phosphate receptors and PKC, respectively, each activating a distinct set of intracellular pathways that could converge on and upregulate Speedy E2's activity. Ionomycin, through its ability to raise intracellular calcium levels, and A23187, as a calcium ionophore, could both enhance Speedy E2 by activating calcium-dependent protein kinases that phosphorylate targets within Speedy E2's signaling network. Similarly, LY294002's inhibition of PI3K, Epigallocatechin gallate (EGCG)'s broad kinase inhibition, and U0126's targeted inhibition of MEK1/2 could lead to a compensatory upregulation of Speedy E2's activity by altering the equilibrium of cellular signaling cascades.
Further enhancing the activity of Speedy E2, SB203580's inhibition of p38 MAPK creates a condition that may favor the enhancement of Speedy E2's signaling pathways by reducing competitive and negative regulatory elements within the cell. Thapsigargin, by disrupting calcium homeostasis, indirectly promotes Speedy E2 activity through the initiation of calcium-dependent signaling that interacts with Speedy E2. Genistein, byinhibiting tyrosine kinases, decreases signaling competition, thereby potentially enhancing the activity of Speedy E2 by allowing its associated pathways to become more prominent. Lastly, Staurosporine serves a unique role as a broad-spectrum protein kinase inhibitor, which, while generally inhibitory, may paradoxically enhance Speedy E2 by selectively lifting the inhibition exerted by specific kinases that otherwise suppress Speedy E2-related processes. Collectively, these chemical activators enhance the functional activity of Speedy E2 by strategically modulating various signaling pathways and molecular interactions that are crucial for Speedy E2's role in cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates intracellular cAMP levels, which in turn activates cAMP-dependent protein kinase A (PKA). PKA phosphorylation can enhance the activity of Speedy E2 by phosphorylating substrates that interact with or modify Speedy E2 function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Acts on sphingosine-1-phosphate receptors to activate intracellular signaling cascades, including those that could enhance the function of Speedy E2 through downstream effects. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which can enhance Speedy E2 activity through phosphorylation of proteins that are part of Speedy E2's signaling network. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium levels, potentially enhancing Speedy E2 activity by activating calcium-dependent protein kinases that interact with Speedy E2's functional pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially upregulating Speedy E2 activity by altering downstream signaling pathways that include Speedy E2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Inhibits multiple kinases, potentially enhancing Speedy E2 activity by reducing competitive signaling and allowing for Speedy E2's signaling pathway to be more predominant. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, which may enhance Speedy E2 activity by impacting downstream signaling elements that interact with Speedy E2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, which can shift signaling to pathways that enhance Speedy E2's activity, as p38 MAPK can regulate proteins that interact with Speedy E2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis, which can enhance Speedy E2 activity through calcium-dependent signaling pathways that Speedy E2 may interact with. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore that increases intracellular calcium, potentially enhancing Speedy E2 activity via calcium-dependent protein kinases that could phosphorylate proteins within Speedy E2's signaling pathway. | ||||||